LBCTR2020093402 | IMR-BTL-201 | A Phase 2 Study to Evaluate the Safety and Tolerability of IMR-687 in Subjects with Beta Thalassemia | A Phase 2 Study to Evaluate the Safety and Tolerability of IMR-687 in Subjects with Beta Thalassemia | Interventional | Pending | 24/02/2020 |
LBCTR2020083421 | IMR-SCD-301 | A Phase 2b Study to Evaluate the Safety and Efficacy of IMR-687 in Subjects with Sickle Cell Disease | A Phase 2b Study to Evaluate the Safety and Efficacy of IMR-687 in Subjects with Sickle Cell Disease | Interventional | Pending | 26/08/2020 |
LBCTR2020043428 | APD334-303 | An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis | An Open-Label Extension Study of Etrasimod in Subjects With Moderately to Severely Active Ulcerative Colitis | Interventional | Pending | 01/12/2020 |
LBCTR2020043459 | HDF 1632 | The effect of confinement on the mental health of individuals during the COVID-19 pandemic: an online survey | The effect of confinement on the mental health of individuals during the COVID-19 pandemic: an online survey | Observational | Pending | 16/04/2020 |
LBCTR2020063508 | WIL-31 | CLINICAL STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF WILATE DURING PROPHYLAXIS IN PREVIOUSLY TREATED PATIENTS WITH VON WILLEBRAND DISEASE (VWD) | CLINICAL STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF WILATE DURING PROPHYLAXIS IN PREVIOUSLY TREATED PATIENTS WITH VON WILLEBRAND DISEASE (VWD) | Interventional | Pending | 09/06/2020 |
LBCTR2021024523 | GC1801 | Phase 3 study to evaluate the efficacy and safety of human plasma-derived fibrinogen concentrate (FIB Grifols) in subjects with congenital afibrinogenaemia and severe hypofibrinogenemia | A prospective, multicenter, open-label, single-arm study to evaluate the efficacy and safety of human plasma-derived fibrinogen concentrate (FIB Grifols) in subjects with congenital afibrinogenaemia and severe hypofibrinogenemia requiring either ondemand treatment for acute bleeding or surgical prophylaxis | Interventional | Pending | 14/07/2020 |
LBCTR2020094566 | FGCL-3019-095 | Zephyrus II: Efficacy and Safety Study of Pamrevlumab in Subjects With Idiopathic Pulmonary Fibrosis (IPF) | Zephyrus II: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Pamrevlumab in Subjects with Idiopathic Pulmonary Fibrosis (IPF) | Interventional | Pending | 01/03/2021 |
LBCTR2020104612 | BIO-2019-0257 | Impact of Phosphorus Ingestion with Fructose and Glucose on Substrate Utilization in Active Individuals During Moderate Exercise | Impact of Phosphorus Ingestion with Fructose and Glucose on Substrate Utilization in Active Individuals During Moderate Exercise | Interventional | Pending | 08/10/2020 |
LBCTR2021014651 | 000000 | Managing Endothelial Dysfunction in COVID-19: A Randomized Clinical Trial at the Lebanese American University Medical Center- Rizk Hospital | Managing Endothelial Dysfunction in COVID-19: A Randomized Clinical Trial at the Lebanese American University Medical Center- Rizk Hospital | Interventional | Pending | 07/02/2021 |
LBCTR2020043495 | Solidarity-Lebanon2020 | An international randomised trial of additional treatments for COVID-19 in hospitalised patients who are all receiving the local standard of care | An international randomised trial of additional treatments for COVID-19 in hospitalised patients who are all receiving the local standard of care | Interventional | Pending | 22/04/2020 |